The prognostic and predictive potential of Ki-67 in triple-negative breast cancer

As a cell proliferation biomarker, Ki-67 is principally used in ER+/HER2− breast cancer. However, the importance and the best cutoff point of Ki-67 in triple-negative breast cancer (TNBC) remains unclear and was evaluated in this study.A total of 1800 patients with early invasive TNBC between 2011 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiuzhi, Chen, Li, Huang, Binhao, Wang, Yue, Ji, Lei, Wu, Jiong, Di, Genhong, Liu, Guangyu, Yu, Keda, Shao, Zhimin, Wang, Zhonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959292/
https://www.ncbi.nlm.nih.gov/pubmed/31937819
http://dx.doi.org/10.1038/s41598-019-57094-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959292/
https://www.ncbi.nlm.nih.gov/pubmed/31937819
http://dx.doi.org/10.1038/s41598-019-57094-3

Ejemplares similares